These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 27521792

  • 1. Adenosine monophosphate-activated protein kinase attenuates cardiomyocyte hypertrophy through regulation of FOXO3a/MAFbx signaling pathway.
    Chen B, Wu Q, Xiong Z, Ma Y, Yu S, Chen D, Huang S, Dong Y.
    Acta Biochim Biophys Sin (Shanghai); 2016 Sep; 48(9):827-32. PubMed ID: 27521792
    [Abstract] [Full Text] [Related]

  • 2. Activation of AMPK inhibits cardiomyocyte hypertrophy by modulating of the FOXO1/MuRF1 signaling pathway in vitro.
    Chen BL, Ma YD, Meng RS, Xiong ZJ, Wang HN, Zeng JY, Liu C, Dong YG.
    Acta Pharmacol Sin; 2010 Jul; 31(7):798-804. PubMed ID: 20581852
    [Abstract] [Full Text] [Related]

  • 3. AMP-activated protein kinase enhances the expression of muscle-specific ubiquitin ligases despite its activation of IGF-1/Akt signaling in C2C12 myotubes.
    Tong JF, Yan X, Zhu MJ, Du M.
    J Cell Biochem; 2009 Oct 01; 108(2):458-68. PubMed ID: 19639604
    [Abstract] [Full Text] [Related]

  • 4. AMP-activated protein kinase agonists increase mRNA content of the muscle-specific ubiquitin ligases MAFbx and MuRF1 in C2C12 cells.
    Krawiec BJ, Nystrom GJ, Frost RA, Jefferson LS, Lang CH.
    Am J Physiol Endocrinol Metab; 2007 Jun 01; 292(6):E1555-67. PubMed ID: 17264220
    [Abstract] [Full Text] [Related]

  • 5. AMPK promotes skeletal muscle autophagy through activation of forkhead FoxO3a and interaction with Ulk1.
    Sanchez AM, Csibi A, Raibon A, Cornille K, Gay S, Bernardi H, Candau R.
    J Cell Biochem; 2012 Feb 01; 113(2):695-710. PubMed ID: 22006269
    [Abstract] [Full Text] [Related]

  • 6. Atrogin-1/MAFbx enhances simulated ischemia/reperfusion-induced apoptosis in cardiomyocytes through degradation of MAPK phosphatase-1 and sustained JNK activation.
    Xie P, Guo S, Fan Y, Zhang H, Gu D, Li H.
    J Biol Chem; 2009 Feb 27; 284(9):5488-96. PubMed ID: 19117950
    [Abstract] [Full Text] [Related]

  • 7. AMPK activation stimulates myofibrillar protein degradation and expression of atrophy-related ubiquitin ligases by increasing FOXO transcription factors in C2C12 myotubes.
    Nakashima K, Yakabe Y.
    Biosci Biotechnol Biochem; 2007 Jul 27; 71(7):1650-6. PubMed ID: 17617726
    [Abstract] [Full Text] [Related]

  • 8. Insulin down-regulates the expression of ubiquitin E3 ligases partially by inhibiting the activity and expression of AMP-activated protein kinase in L6 myotubes.
    Deng HP, Chai JK, Shen CA, Zhang XB, Ma L, Sun TJ, Hu QG, Chi YF, Dong N.
    Biosci Rep; 2015 Jul 20; 35(4):. PubMed ID: 26193886
    [Abstract] [Full Text] [Related]

  • 9. The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling.
    Skurk C, Izumiya Y, Maatz H, Razeghi P, Shiojima I, Sandri M, Sato K, Zeng L, Schiekofer S, Pimentel D, Lecker S, Taegtmeyer H, Goldberg AL, Walsh K.
    J Biol Chem; 2005 May 27; 280(21):20814-23. PubMed ID: 15781459
    [Abstract] [Full Text] [Related]

  • 10. Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy.
    Li HL, Yin R, Chen D, Liu D, Wang D, Yang Q, Dong YG.
    J Cell Biochem; 2007 Apr 01; 100(5):1086-99. PubMed ID: 17266062
    [Abstract] [Full Text] [Related]

  • 11. AMPK activation enhances PPARα activity to inhibit cardiac hypertrophy via ERK1/2 MAPK signaling pathway.
    Meng R, Pei Z, Zhang A, Zhou Y, Cai X, Chen B, Liu G, Mai W, Wei J, Dong Y.
    Arch Biochem Biophys; 2011 Jul 01; 511(1-2):1-7. PubMed ID: 21530483
    [Abstract] [Full Text] [Related]

  • 12. AICAR-induced activation of AMPK negatively regulates myotube hypertrophy through the HSP72-mediated pathway in C2C12 skeletal muscle cells.
    Egawa T, Ohno Y, Goto A, Ikuta A, Suzuki M, Ohira T, Yokoyama S, Sugiura T, Ohira Y, Yoshioka T, Goto K.
    Am J Physiol Endocrinol Metab; 2014 Feb 01; 306(3):E344-54. PubMed ID: 24347059
    [Abstract] [Full Text] [Related]

  • 13. MAFbx/Atrogin-1 is required for atrophic remodeling of the unloaded heart.
    Baskin KK, Rodriguez MR, Kansara S, Chen W, Carranza S, Frazier OH, Glass DJ, Taegtmeyer H.
    J Mol Cell Cardiol; 2014 Jul 01; 72():168-76. PubMed ID: 24650875
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Forkhead box O3 plays a role in skeletal muscle atrophy through expression of E3 ubiquitin ligases MuRF-1 and atrogin-1 in Cushing's syndrome.
    Kang SH, Lee HA, Kim M, Lee E, Sohn UD, Kim I.
    Am J Physiol Endocrinol Metab; 2017 Jun 01; 312(6):E495-E507. PubMed ID: 28246104
    [Abstract] [Full Text] [Related]

  • 16. Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy.
    Kim J, Wende AR, Sena S, Theobald HA, Soto J, Sloan C, Wayment BE, Litwin SE, Holzenberger M, LeRoith D, Abel ED.
    Mol Endocrinol; 2008 Nov 01; 22(11):2531-43. PubMed ID: 18801929
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Metabolic switch and hypertrophy of cardiomyocytes following treatment with angiotensin II are prevented by AMP-activated protein kinase.
    Stuck BJ, Lenski M, Böhm M, Laufs U.
    J Biol Chem; 2008 Nov 21; 283(47):32562-9. PubMed ID: 18790741
    [Abstract] [Full Text] [Related]

  • 20. [Effects of AMPK on the transcriptional activity of FOXO1 and ubiquitin ligase MuRF1 expression in rat cardiomyocytes].
    Chen BL, Xiong ZJ, Zhang CX, Ma YD, Meng RS, Chen GQ, Liu C, Dong YG.
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Nov 21; 30(11):2419-22. PubMed ID: 21097394
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.